Tag: GSKs

  • GSK’s Arexvy Vaccine Positive aspects Constructive CHMP Opinion for Adults 18 and Up

    GSK’s Arexvy Vaccine Positive aspects Constructive CHMP Opinion for Adults 18 and Up

    Advertising authorisation anticipated in February 2026 Yearly a mean of 158,000 adults are hospitalised with RSV-related sickness within the EU1  GSK plc (LSE/NYSE: GSK) right this moment introduced that the European Medicines Company’s (EMA) Committee for Medicinal Merchandise for Human Use (CHMP) has beneficial increasing the indication of its adjuvanted recombinant respiratory syncytial virus (RSV)…